GURU.Markets stock price, segment price, and overall market index valuation
The company's share price ChromaDex Corporation
ChromaDex is a company that produces and markets the ingredient Niagen (a form of vitamin B3), marketed as an anti-aging treatment. Its stock price reflects both scientific research and marketing, as well as the company's ability to demonstrate its product's effectiveness to consumers.
Share prices of companies in the market segment - Food other
ChromaDex Corporation is a biotechnology company that researches and commercializes ingredients for healthy aging, specifically nicotinamide riboside (NR). We've categorized it under "Other Foods." The chart below shows how the longevity trend is impacting the dietary supplement market.
Broad Market Index - GURU.Markets
ChromaDex is a biotech company that produces and markets ingredients and supplements for healthy aging, specifically those based on nicotinamide riboside. Its scientific approach makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how ChromaDex compares to it.
Change in the price of a company, segment, and market as a whole per day
CDXC - Daily change in the company's share price ChromaDex Corporation
ChromaDex Corporation's daily price change reflects volatility in the dietary supplement market. The indicator demonstrates sensitivity to consumer demand for its Niagen product, serving as an indicator of healthy aging trends.
Daily change in the price of a set of shares in a market segment - Food other
ChromaDex Corporation is a biotechnology company focused on the research and commercialization of ingredients for healthy aging, specifically nicotinamide riboside. The chart below illustrates the volatility of the nutraceutical sector, reflecting the risks and potential associated with scientific research.
Daily change in the price of a broad market stock, index - GURU.Markets
ChromaDex is the company behind the popularization of nicotinamide riboside (NR), an anti-aging ingredient. The company's stock reflects consumer trends in the wellness sector. Its movements are part of a larger consumer market picture that influences overall volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization ChromaDex Corporation
ChromaDex Corporation's year-over-year performance tells the story of its flagship ingredient, Niagen® (nicotinamide riboside). Its 12-month market cap growth reflects its success in selling its Tru Niagen® supplements, as well as its scientific research confirming the product's benefits for cellular health and anti-aging.
Annual dynamics of market capitalization of the market segment - Food other
ChromaDex, through its Niagen product, is the market leader in NAD+ boosters, a popular anti-aging supplement. The company's success depends on scientific evidence and its ability to build a consumer brand. Its performance relative to the industry will reveal how much investors believe in the potential of this emerging nutraceutical segment.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
ChromaDex, with its Niagen product, is a hybrid of science and consumer brand. Its performance relative to the market tells the story of how much consumers believe in scientific evidence about anti-aging. Successful marketing and positive research are allowing it to grow faster than the market.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization ChromaDex Corporation
ChromaDex is a company that produces the ingredient Niagen (NR) for dietary supplements. Its monthly growth reflects sales growth for its own brand, Tru Niagen, and for its ingredient sold to other companies. News about scientific research and partnerships are key.
Monthly dynamics of market capitalization of the market segment - Food other
ChromaDex Corporation is the company behind the commercialization of Niagen (nicotinamide riboside), an ingredient for healthy aging. This nutraceutical sector lies at the intersection of science and consumer products. The chart below shows how investors assessed the scientific validity and commercial potential of anti-aging supplements.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
ChromaDex is a company that produces ingredients for healthy aging, specifically nicotinamide riboside. Its success depends on scientific evidence of the benefits of its products and growing consumer demand for dietary supplements. Its stock price reflects trends in the nutraceutical sector.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization ChromaDex Corporation
ChromaDex Corporation produces and markets the ingredient nicotinamide riboside (NR), marketed as a supplement for healthy aging. Its weekly stock price is driven by scientific research, marketing efforts, and regulations in the dietary supplement market.
Weekly dynamics of market capitalization of the market segment - Food other
ChromaDex Corporation produces ingredients for dietary supplements, specifically those based on nicotinamide riboside (NR). Its success depends on scientific research and consumer demand for longevity products. The chart will show whether the company is moving along with the overall nutraceutical sector or whether its scientific foundation is creating its own investment trend.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
ChromaDex is a company operating in the dietary supplement and nutraceutical industries. Its business is dependent on healthy lifestyle trends and consumer preferences. The chart shows how this niche growth story allows it to move independently of the broader market, reflecting its confidence in its products.
Market capitalization of the company, segment and market as a whole
CDXC - Market capitalization of the company ChromaDex Corporation
ChromaDex's market capitalization reflects its focus on one key ingredient—nicotinamide riboside (NR), marketed as an anti-aging supplement under the brand name Tru Niagen. Its volatile chart reflects how investors evaluate the scientific evidence supporting its effectiveness and its ability to protect its patents.
CDXC - Share of the company's market capitalization ChromaDex Corporation within the market segment - Food other
ChromaDex is a company at the intersection of nutraceuticals and biotechnology. Its market share in the dietary supplements and functional foods sector reflects market interest in its core cellular health product. This metric demonstrates its standing among manufacturers of innovative ingredients for healthy aging.
Market capitalization of the market segment - Food other
Below is a chart of the total market capitalization of the nutraceuticals and healthy nutrition sector. ChromaDex is the company behind the ingredient Niagen (nicotinamide riboside), which is marketed as an anti-aging treatment. The dynamics of this market reflect the global trend toward longevity, and ChromaDex aims to become a scientific leader.
Market capitalization of all companies included in a broad market index - GURU.Markets
ChromaDex is the company behind Niagen, a patented form of nicotinamide riboside (NR) that promotes NAD+ levels and healthy aging. Its market cap is a bet on longevity science. The chart below shows the weight of the dietary supplement industry.
Book value capitalization of the company, segment and market as a whole
CDXC - Book value capitalization of the company ChromaDex Corporation
ChromaDex's foundation is its intellectual property for the ingredient Niagen (nicotinamide riboside), its manufacturing facilities, and the Tru Niagen brand. The chart shows how a company operating at the intersection of science and consumer products builds its material foundation by investing in research and marketing of its core product.
CDXC - Share of the company's book capitalization ChromaDex Corporation within the market segment - Food other
ChromaDex Corporation produces ingredients for healthy aging. The chart shows its share of real assets. These include its laboratories and manufacturing facilities where nicotinamide riboside, its key material product, is synthesized and purified.
Market segment balance sheet capitalization - Food other
ChromaDex Corporation focuses on the science of healthy aging, producing ingredients such as nicotinamide riboside. Their business requires laboratories and manufacturing facilities to ensure product purity. The book value chart shows the value of this research and production base.
Book value of all companies included in the broad market index - GURU.Markets
ChromaDex's balance sheet includes laboratories and production facilities for creating their patented dietary supplement ingredients, such as nicotinamide riboside. The chart shows the growth of the company's resources, which operates at the intersection of science and nutraceuticals.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - ChromaDex Corporation
ChromaDex Corporation promotes ingredients for healthy aging, and its main assets are its patents and brand, not its factories. The chart below illustrates how the market values these intangible assets above their modest book value. The dynamics will show how scientific publications and marketing successes influence this premium.
Market to book capitalization ratio in a market segment - Food other
ChromaDex is a company focused on healthy aging science and known for its dietary supplement ingredient. Its core assets are its patents, clinical trials, and scientific reputation. This chart clearly demonstrates the premium investors are willing to pay for its intellectual property, which significantly exceeds the value of its tangible assets.
Market to book capitalization ratio for the market as a whole
ChromaDex operates in the dietary supplements and nutraceuticals sector, where both patents and production assets are important. This chart shows how much the market values the company's scientific developments and brand over its physical assets. A premium to the market may indicate investor confidence in the uniqueness and effectiveness of its products, such as Niagen.
Debts of the company, segment and market as a whole
CDXC - Company debts ChromaDex Corporation
ChromaDex Corporation is a pioneer in the research of nicotinamide riboside (NR), a component associated with health and aging. This chart shows how the company funds its research and marketing of its Tru Niagen product. The financial strategy is aimed at creating and developing a new category in nutraceuticals.
Market segment debts - Food other
ChromaDex Corporation focuses on the science of healthy aging, specifically the ingredient nicotinamide riboside. Building a science-driven consumer brand requires investment in both research and marketing. This chart helps understand how the company's financial strategy aligns with its innovative business model.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio ChromaDex Corporation
ChromaDex Corporation produces ingredients for dietary supplements, specifically those based on nicotinamide riboside. This chart shows its financial structure. For a company creating a market for a new product, investing in research and marketing is essential. High debt can limit these opportunities and create risks until stable profitability is achieved.
Market segment debt to market segment book capitalization - Food other
ChromaDex Corporation specializes in healthy aging ingredients, specifically nicotinamide riboside (NR). This chart shows the debt burden in the nutraceuticals and dietary supplements sector. It helps understand how companies in this industry finance their clinical research, marketing, and intellectual property protection.
Debt to book value of all companies in the market
ChromaDex Corporation focuses on nutraceuticals, particularly ingredients for healthy aging. Growth in the consumer sector requires investment in research and marketing. This total market debt chart allows you to assess how the company finances its scientific foundation and brand promotion—through profits or debt.
P/E of the company, segment and market as a whole
P/E - ChromaDex Corporation
ChromaDex Corporation specializes in healthy aging ingredients, its flagship product being niacinamide riboside (NR), marketed under the brand name Tru Niagen®, which helps boost NAD+ levels. This chart reflects investor confidence in the growing market for nutraceuticals and longevity supplements.
P/E of the market segment - Food other
ChromaDex Corporation is a scientific company pioneering the study of nicotinamide riboside (NR), an ingredient that increases NAD+ levels in the body, which is associated with healthy aging. Their product, Tru Niagen, is a leader in this niche. This chart shows the average valuation for the nutrition sector, reflecting how investors value companies operating at the intersection of science and consumer products.
P/E of the market as a whole
ChromaDex is a company that develops and markets ingredients for dietary supplements, specifically nicotinamide riboside (NR), which is associated with aging. Its valuation is a bet on the growth of the anti-aging supplement market. This general sentiment influences consumer spending, but for ChromaDex, scientific evidence of its product's effectiveness is more important.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company ChromaDex Corporation
ChromaDex Corporation is the company behind Niagen, a patented form of nicotinamide riboside that promotes cellular health. This chart shows market expectations for sales growth of this nutraceutical. Future profits depend on scientific research confirming its benefits and expanded distribution.
%20P%2FE%20ChromaDex%20Corporation&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-ChromaDex-Corporation&v=1772513912140 "Chart of the company's future (projected) P/E ChromaDex Corporation")
Future (projected) P/E of the market segment - Food other
ChromaDex Corporation specializes in aging science, producing ingredients and consumer products based on nicotinamide riboside (NR). This chart shows general expectations for the consumer health products sector. ChromaDex's position relative to the average reflects investors' confidence in the scientific basis of its products and the commercial potential of the anti-aging supplement market.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Food%20other&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Food-other&v=1772513912175 "Future (projected) P/E graph of the market segment - Food other")
Future (projected) P/E of the market as a whole
ChromaDex Corporation is a biotech company focused on healthy aging. Its flagship ingredient, Niagen (nicotinamide riboside), increases NAD+ levels in cells and is sold as a dietary supplement. This overall market sentiment chart helps assess investor confidence in the growth of the wellness industry and consumer longevity science.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513912202 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit ChromaDex Corporation
ChromaDex Corporation specializes in healthy aging ingredients, primarily nicotinamide riboside (NR), sold under the brand name Tru Niagen. The profit chart shows how successfully the company is marketing its product. Profitability depends on sales growth and the effectiveness of marketing investments in promoting the supplement.
Profit of companies in the market segment - Food other
ChromaDex Corporation specializes in healthy aging ingredients, specifically nicotinamide riboside (NR), sold under the brand name Tru Niagen. This chart shows total revenue in the nutritional products sector. It helps understand consumer trends in wellness and nutraceuticals, as well as the level of competition in this rapidly growing market.
Overall market profit
ChromaDex Corporation is engaged in the scientific research and commercialization of nicotinamide riboside (NR), an ingredient for healthy aging. Demand for its products depends on consumer spending on dietary supplements. During periods of economic growth, as reflected in this graph, people spend more on health maintenance and preventative care, which drives ChromaDex sales.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company ChromaDex Corporation
ChromaDex Corporation is a company focused on healthy aging research, known for its ingredient Niagen (nicotinamide riboside). This chart reflects analysts' expectations for sales growth of this dietary supplement ingredient, which is a key driver of future profitability and recognition of its health benefits.
%20profit%20of%20the%20company%20ChromaDex%20Corporation&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-ChromaDex-Corporation&v=1772513912364 "Graph of future (projected) profit of the company ChromaDex Corporation")
Future (predicted) profit of companies in the market segment - Food other
ChromaDex Corporation specializes in the production of dietary supplement ingredients, specifically nicotinamide riboside (NR), which supports cellular health. The company's success depends on scientific research and consumer demand for longevity products. This chart reflects forecasts for the dietary supplement industry, providing context for assessing ChromaDex's niche.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Food%20other&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Food-other&v=1772513912367 "Graph of future (predicted) profits of companies in a market segment - Food other")
Future (predicted) profit of the market as a whole
ChromaDex Corporation produces ingredients for dietary supplements, particularly those related to healthy aging. Demand for these products depends on consumer discretionary spending. This graph, reflecting overall economic health, helps predict whether people will spend money on improving their quality of life and preventing aging.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513912414 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - ChromaDex Corporation
ChromaDex is behind the popular supplement Niagen, which targets the healthy aging market. This chart shows the investors' confidence in the product's science and the growing consumer demand for nutraceuticals. This is a bet on a long-term trend in the wellness industry and the company's ability to protect its intellectual property.
P/S market segment - Food other
ChromaDex Corporation focuses on the science of healthy aging, selling its key ingredient in dietary supplements. Revenue is generated from sales of this component. This metric, which is relevant to the nutraceutical sector, helps assess how investors value ChromaDex's scientific foundation and the commercial potential of its products in the growing longevity industry.
P/S of the market as a whole
ChromaDex Corporation is a biotech company focused on healthy aging. Its flagship product, Tru Niagen, contains nicotinamide riboside, which helps increase NAD+ levels in cells. This total market revenue valuation chart helps understand how investors value this science-intensive business in the fast-growing dietary supplements and nutraceuticals industry.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company ChromaDex Corporation
ChromaDex Corporation is a company focused on healthy aging research, best known for its NAD+-boosting ingredient Niagen (nicotinamide riboside). This chart shows how investors view the future sales of this supplement ingredient. It reflects their belief in the growth of the longevity market and the company's scientific foundation.
%20P%2FS%20ChromaDex%20Corporation&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-ChromaDex-Corporation&v=1772513912624 "The graph of the company's future (projected) P/S ChromaDex Corporation")
Future (projected) P/S of the market segment - Food other
ChromaDex is a science-based company behind the commercialization of Niagen (nicotinamide riboside), an ingredient for increasing NAD+ levels in the body, which is associated with cellular health and aging. The company's valuation reflects investor expectations for the growth of the longevity supplement market and the scientific validation of its product, despite competition.
%20P%2FS%20market%20segment%20graph%20-%20Food%20other&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Food-other&v=1772513912674 "Future (projected) P/S market segment graph - Food other")
Future (projected) P/S of the market as a whole
ChromaDex Corporation focuses on the science of aging, producing ingredients for nutraceuticals. The company's growth is driven by the global trend toward healthy living and longevity. This chart illustrates general expectations, and ChromaDex represents a rapidly growing segment of the consumer health market.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513912684 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales ChromaDex Corporation
ChromaDex Corporation specializes in ingredients for healthy aging. This chart shows sales revenue for its flagship product, Niagen (nicotinamide riboside), which is sold both directly to consumers under the Tru Niagen brand and as an ingredient for other companies in the dietary supplement sector.
Sales of companies in the market segment - Food other
ChromaDex Corporation (CDXC) is dedicated to the science of healthy aging, producing the ingredient Niagen® (nicotinamide riboside), which increases NAD+ levels in cells. This chart shows total revenue in the dietary supplements sector. ChromaDex is a science-intensive player in this market, whose success depends on growing consumer interest in longevity products.
Overall market sales
ChromaDex Corporation is a manufacturer of dietary supplements based on nicotinamide riboside (NR), which promotes cellular metabolism. Demand for nutraceuticals is driven by consumer spending on health products. This graph of overall economic activity shows how much people are willing to spend on non-pharmaceutical products to support health and longevity.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company ChromaDex Corporation
ChromaDex Corporation is a bioscience company focused on the research and commercialization of nicotinamide riboside (NR), a healthy aging ingredient known under the Niagen brand. The company's sales are driven by consumer demand for dietary supplements. This chart reflects analyst revenue forecasts, which are an indicator of the growth of the nutraceutical market and the popularity of its product.
%20sales%20of%20the%20company%20ChromaDex%20Corporation&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-ChromaDex-Corporation&v=1772513912788 "Schedule of future (projected) sales of the company ChromaDex Corporation")
Future (projected) sales of companies in the market segment - Food other
ChromaDex Corporation specializes in healthy aging ingredients, primarily niacinamide (NR). This forecast chart details expected sales of their flagship product, Tru Niagen, across both direct-to-consumer and B2B channels. This demonstrates which strategy, according to analysts, will be more successful.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Food%20other&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Food-other&v=1772513912806 "Schedule of future (projected) sales of companies in the market segment - Food other")
Future (projected) sales of the market as a whole
ChromaDex Corporation is promoting the healthy aging ingredient TRU NIAGEN®. Demand for these products is part of the global wellness and longevity trend. This chart reflects overall consumer spending, and ChromaDex's sales demonstrate the strength of the nutraceutical segment and consumers' willingness to invest in their health and anti-aging.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513912843 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality ChromaDex Corporation
ChromaDex Corporation is behind the popular Tru Niagen supplement, which aims to boost NAD+ levels in the body for healthy aging. The company's profitability depends on the strength of its brand, the effectiveness of direct marketing, and scientific research supporting its product's benefits. This chart shows how the company is monetizing science in the rapidly growing longevity industry.
Market segment marginality - Food other
ChromaDex Corporation is a company focused on healthy aging research, known for its key ingredient, Niagen (nicotinamide riboside), which boosts NAD+ levels. This chart shows the company's profitability. Success depends on scientific evidence of the effectiveness and growing sales of its supplements, such as Tru Niagen.
Market marginality as a whole
ChromaDex Corporation produces ingredients for dietary supplements, including nicotinamide riboside (NR), which promotes healthy aging. Demand for these premium products is driven by discretionary spending. This overall profitability curve is an indicator of consumer financial well-being, as consumers are more likely to spend on dietary supplements and health products during periods of growth.
Employees in the company, segment and market as a whole
Number of employees in the company ChromaDex Corporation
ChromaDex Corporation is behind the popular healthy aging ingredient Niagen. The company actively invests in scientific research to confirm its effectiveness. This chart reflects the size of the team of scientists and marketers who are the driving force behind the product's promotion and expansion into the global nutraceutical market.
Share of the company's employees ChromaDex Corporation within the market segment - Food other
ChromaDex Corporation is behind the scientific research and commercialization of Niagen, an ingredient that promotes healthy aging. The company's success depends on a team of scientists proving its effectiveness and marketers building a consumer brand. This chart illustrates the human capital involved in turning science into a popular health product.
Number of employees in the market segment - Food other
ChromaDex Corporation is focused on the science of healthy aging, specifically the ingredient nicotinamide riboside (NR). This chart, which shows employment in the food technology sector, illustrates the growing interest in nutraceuticals. The growing number of specialists indicates an expanding dietary supplement market, creating both opportunities and competition for ChromaDex.
Number of employees in the market as a whole
ChromaDex Corporation focuses on the science of healthy aging, producing nutraceutical ingredients such as nicotinamide riboside. Demand for these products is driven by consumer discretionary spending. The growth in overall employment, shown in this graph, increases the number of people with stable incomes willing to invest in their health and longevity by purchasing premium dietary supplements.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company ChromaDex Corporation (CDXC)
ChromaDex (CDXC) is behind science-intensive dietary supplement ingredients like their flagship Niagen. Their business is twofold: on one side is R&D and patents, which increase the cost per employee, while on the other side is marketing and sales, which require staff. This chart shows how the market evaluates this balance, weighing the value of their intellectual property against the operating costs of promoting the product.
%20of%20the%20company%20ChromaDex%20Corporation%20(CDXC)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-ChromaDex-Corporation-CDXC&v=1772513913252 "Chart of market capitalization per employee (in thousands of dollars) of the company ChromaDex Corporation (CDXC)")
Market capitalization per employee (in thousands of dollars) in the market segment - Food other
ChromaDex is behind the popular cellular health supplement Niagen. The company's value is derived from scientific research, patents, and the strength of its consumer brand. This chart shows how the market values this intellectual property, which allows it to generate high value for its relatively small workforce.
%20by%20market%20segment%20-%20Food%20other&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Food-other&v=1772513913272 "Market capitalization per employee (in thousands of dollars) by market segment - Food other")
Market capitalization per employee (in thousands of dollars) for the overall market
ChromaDex Corporation is behind Tru Niagen, a form of vitamin B3. The company combines scientific research with consumer marketing in the healthy aging space. This chart evaluates how companies in the nutraceutical industry create value at the intersection of science and brand, as reflected in their market capitalization per employee.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513913291 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company ChromaDex Corporation (CDXC)
ChromaDex is the company behind the popular anti-aging supplement Tru Niagen. It's a nutraceutical business built on a strong brand and a patented ingredient. This chart shows how their "asset-light" business model (focusing on marketing and R&D rather than manufacturing) and direct e-commerce sales enable them to generate high profits.
%20Chart%20ChromaDex%20Corporation%20(CDXC)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-ChromaDex-Corporation-CDXC&v=1772513913343 "Company Profit Per Employee (in thousands of dollars) Chart ChromaDex Corporation (CDXC)")
Profit per employee (in thousands of dollars) in the market segment - Food other
ChromaDex Corporation specializes in the production of dietary supplement ingredients, particularly those that promote healthy aging. The company's success depends on the effectiveness of its scientific research and the commercialization of its developments. This graph depicts the team's productivity, demonstrating how scientific advances translate into financial results.
%20in%20the%20market%20segment%20-%20Food%20other&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Food-other&v=1772513913450 "Chart of profit per employee (in thousands of dollars) in the market segment - Food other")
Profit per employee (in thousands of dollars) for the market as a whole
ChromaDex (CDXC) is the company behind the ingredient Niagen (nicotinamide riboside), used in cellular health supplements. It's a research-intensive business. This chart shows the overall market profit margin per employee. It helps understand how the nutraceuticals and biosciences sector, where value is created through patents and research, is able to generate high profit margins per employee compared to the market average.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513913492 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee ChromaDex Corporation (CDXC)
ChromaDex Corporation specializes in healthy aging ingredients, most notably Niagen (nicotinamide riboside). Its revenue per employee reflects the success of its science-based approach to consumer products. The chart shows how the company sells its key ingredient both directly to consumers and to other manufacturers.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-ChromaDex-Corporation-CDXC&v=1772513913551 "Sales chart per company employee ChromaDex Corporation (CDXC)")
Sales per employee in the market segment - Food other
ChromaDex (CDXC) is a nutraceutical company best known for its ingredient Niagen (vitamin B3), marketed for cellular health and anti-aging. This metric reflects the average revenue per employee in the segment. It helps assess how effectively ChromaDex utilizes its personnel (marketing, sales) to generate revenue from its products compared to other dietary supplement manufacturers.
Sales per employee for the market as a whole
ChromaDex (CDXC) is the science-based company behind Niagen (a form of vitamin B3), which is marketed as a "healthy aging" product. Their business is a hybrid of R&D and CPG (consumer packaged goods). This metric reflects how successfully the company monetizes its intellectual property (patents) and sells the final product (Tru Niagen) per employee.
Short shares by company, segment and market as a whole
Shares shorted by company ChromaDex Corporation (CDXC)
ChromaDex (CDXC) is behind the popular supplement Niagen (nicotinamide riboside), marketed for its anti-aging benefits. This chart shows bearish sentiment. The high level of short positions reflects market skepticism about the science behind dietary supplements, the intense competition in the sector, and the company's history of costly patent litigation. (342)
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-ChromaDex-Corporation-CDXC&v=1772513913647 "Short Shares Chart for the Company ChromaDex Corporation (CDXC)")
Shares shorted by market segment - Food other
ChromaDex (CDXC) focuses on healthy aging ingredients, specifically NAD+ (TRU NIAGEN®). The company operates at the intersection of nutraceuticals and biotech. The chart below reflects the overall short position in the dietary supplement and healthy nutrition sector. It indicates whether the market is expecting a decline in consumer demand for premium supplements.
Shares shorted by the overall market
ChromaDex sells "anti-aging" supplements (Tru Niagen). It's pure "wellness," an unnecessary expense. This graph illustrates the rise of general fear. When consumers fear a recession, they first cut back on expensive supplements promising "future health," preferring to save "here and now."
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator ChromaDex Corporation (CDXC)
ChromaDex (CDXC) is the company behind Niagen (nicotinamide riboside), a popular ingredient in dietary supplements aimed at "healthy aging" (NAD+ stimulation). This chart measures trend strength. It shows when the stock is "overheated" (above 70) due to positive research or "oversold" (below 30) due to competition or weak sales.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-ChromaDex-Corporation-CDXC&v=1772513913739 "RSI 14 indicator chart for the company's stock ChromaDex Corporation (CDXC)")
RSI 14 Market Segment - Food other
ChromaDex is a biotech company specializing in ingredients for "healthy aging." Their flagship product, Niagen (nicotinamide riboside, form B3), increases NAD+ levels. This indicator reflects the overall health of the nutraceutical sector and helps determine whether the entire wellness segment is overheated.
RSI 14 for the overall market
ChromaDex, a dietary supplement manufacturer, sees "premium" spending in this chart. In times of euphoria, consumers are eager to spend on "health" and "youth." In times of panic and recession, when savings are needed, expensive, "non-essential" dietary supplements are an expense they forgo in favor of basic products.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast CDXC (ChromaDex Corporation)
ChromaDex is the company behind Niagen (NR), a popular dietary supplement (a precursor to NAD+) aimed at promoting "healthy aging." This chart shows the analysts' average 12-month forecast, reflecting their view on the scientific validity and consumer demand for anti-aging supplements.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-CDXC-ChromaDex-Corporation&v=1772513913810 "A chart showing analyst consensus forecasts for the expected stock price. CDXC (ChromaDex Corporation)")
The difference between the consensus estimate and the actual stock price CDXC (ChromaDex Corporation)
ChromaDex (CDXC) is the "science of aging." The company produces and sells Tru Niagen, a patented form of the "vitamin" NR, believed to boost NAD+ levels (a key component of metabolism). This chart illustrates the analyst community's opinion on the company's future. It measures the distance between the stock price and the target, reflecting their belief in this "anti-aging" market.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-CDXC-ChromaDex-Corporation&v=1772513913819 "A chart showing the difference between the consensus forecast and the actual stock price. CDXC (ChromaDex Corporation)")
Analyst consensus forecast for stock prices by market segment - Food other
ChromaDex (CDXC) is the company behind Niagen, a patented form of nicotinamide riboside (NR), a supplement for "healthy aging" and boosting NAD+ levels. This chart shows general expectations for the nutraceutical sector. It reflects whether experts believe the anti-aging supplement market will grow.
Analysts' consensus forecast for the overall market share price
ChromaDex (CDXC) is a company behind "longevity science." Their flagship product is Tru Niagen (nicotinamide riboside), a dietary supplement believed to boost cellular energy (NAD+). This chart shows the general sentiment of experts. It reflects the extent to which analysts believe consumers are willing to spend "extra" money on premium "wellness" products.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index ChromaDex Corporation
ChromaDex is the science of aging. Their signature feature is their patented Niagen (NR), a key ingredient (a precursor to NAD+) that acts as a fuel for cells. They sell both raw materials (B2B) and their D2C brand (Tru Niagen). This chart summarizes their implementation history. It reflects their (slow) sales growth of this vitamin and their (uphill) struggle for profitability.
AKIMA Market Segment Index - Food other
ChromaDex is the science of longevity. Their flagship product is Niagen, a form of vitamin B3 (NR), believed to boost NAD+ levels and slow aging. They're food tech at the intersection of pharma and nutrition. This chart compares their composite index to the sector, showing how their anti-aging product outperforms the competition.
The AKIM Index for the overall market
ChromaDex is a scientific nutraceutical company known for its ingredient Niagen (nicotinamide riboside) for healthy aging. This chart, reflecting the market average, is a backdrop. It helps assess how this growth story in the dietary supplement sector compares to overall macroeconomic trends.
